Zhang, L., Lu, S., Feng, J., Dechaphunkul, A., Chang, J., Wang, D., Chessari, S., Lanzarotti, C., Jordan, K., & Aapro, M. (2018). a randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). Annals of oncology, 29, 452–458. http://access.bl.uk/ark:/81055/vdc_100095487119.0x00003d